These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24195508)

  • 1. Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.
    Smetana J; Dementyeva E; Kryukov F; Nemec P; Greslikova H; Kupska R; Mikulasova A; Ihnatova I; Hajek R; Kuglik P
    Neoplasma; 2014; 61(1):48-55. PubMed ID: 24195508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
    Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can genome array screening replace FISH as a front-line test in multiple myeloma?
    Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
    Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.
    Cook JR; Hartke M; Pettay J; Tubbs RR
    J Mol Diagn; 2006 Sep; 8(4):459-65. PubMed ID: 16931586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
    Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
    Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
    Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations.
    Largo C; Saéz B; Alvarez S; Suela J; Ferreira B; Blesa D; Prosper F; Calasanz MJ; Cigudosa JC
    Haematologica; 2007 Jun; 92(6):795-802. PubMed ID: 17550852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on molecular cytogenetic abnormalities in multiple myeloma].
    Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
    Praulich I; Tauscher M; Göhring G; Glaser S; Hofmann W; Feurstein S; Flotho C; Lichter P; Niemeyer CM; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2010 Oct; 49(10):885-900. PubMed ID: 20589934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.